Inventor · Zagreb, HR

Milan Mesic

19Patents
2h-index
37Co-inventors
50Inventor score

Filing activity: Jan 3, 2002 → Dec 24, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US7157433B2 Compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules Chemistry; Metallurgy 32 Expired
US7091187B2 Compounds, compositions and methods for treatment of inflammatory diseases and conditions Human Necessities 4 Expired
US7579334B2 Compounds with anti-inflammatory activity Chemistry; Metallurgy 2 Active
US7109176B2 Nonsteroidal anti-inflammatory substances, compositions and methods for their use Human Necessities 2 Expired
US10919910B2 Seco macrolide compounds Chemistry; Metallurgy 2 Active
US7312203B2 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof Emerging Cross-Sectional Technologies 1 Expired
US7262302B2 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof Human Necessities 1 Expired
US7435834B2 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof Emerging Cross-Sectional Technologies 1 Expired
US7384975B2 Substituted furochromenes, preparation thereof and their antiinflammatory action Human Necessities 1 Expired
US7208518B2 Substituted furochromene compounds of antiinflammatory action Human Necessities 1 Expired
US7166583B2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof Chemistry; Metallurgy 0 Expired
US7232815B2 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof Emerging Cross-Sectional Technologies 0 Expired
US6897211B2 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors Human Necessities 0 Expired
US7928078B2 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy Human Necessities 0 Active
US7550498B2 1,2-Diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof Chemistry; Metallurgy 0 Expired
US7446097B2 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy Human Necessities 0 Expired
US7262309B2 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof Emerging Cross-Sectional Technologies 0 Expired
US11512096B2 Seco macrolide compounds Chemistry; Metallurgy 0 Active
US11136325B2 Pyrrolopyrimidine and pyrrolopyridine derivatives Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.